Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram versus pramipexole for depression in Parkinson's disease
IRCT20191111045407N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in depression in Parkinson's disease comparing Pramipexole with Citalopram (2 arms). Primary endpoints: Change in Beck Depression Inventory total score and Change in Parkinson's Disease Questionnaire-39 total score. Started Jan 2020; status: completed.
02
Drugs
citaloprampramipexole
03
Conditions
depression in Parkinson's disease
Beyond the preview
Go deeper on IRCT20191111045407N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191111045407N1.